Many people today are being prescribed a drug called Vascepa for their heart.
And because Vascepa is derived from omega 3 fatty acids, many people assume it is simply a stronger form of fish oil. In reality, it is something very different.
Vascepa is a pharmaceutical drug that contains a chemically modified form of one isolated omega 3 fatty acid. While the data shows it may provide some benefit in certain patients, the story behind the drug, the trial data, and the potential side effects are important to understand.
Most importantly, the benefits attributed to Vascepa are often exaggerated when compared with the simple act of eating real seafood.
What Is Vascepa
Vascepa is the brand name for a drug called icosapent ethyl.
It is a highly purified and chemically modified version of the omega 3 fatty acid EPA, which is naturally found in fish.
However, Vascepa does not contain the full spectrum of nutrients found in seafood. When fish are consumed as food, they provide a complex package of nutrients that work together in the body.
These include:
- EPA
- DHA
- Marine phospholipids
- Astaxanthin
- Vitamin D
- Selenium
- Iodine
- High quality protein and more
Vascepa removes this entire nutritional ecosystem and delivers only a single isolated compound.
Who Is Prescribed Vascepa
Vascepa is typically prescribed to people who:
- Have elevated triglycerides
- Have existing cardiovascular disease
- Have diabetes with additional cardiovascular risk factors
- Are already taking statins but remain at elevated risk
Nearly all patients in the major clinical trial were already taking statin drugs.
Vascepa was therefore studied as an add-on medication rather than a standalone therapy.
The REDUCE-IT Trial
The main trial used to support Vascepa is called REDUCE-IT.
This study included about 8,179 patients and followed them for nearly five years.
Participants were randomly assigned to receive either:
- Statin therapy plus Vascepa
- Statin therapy plus placebo
The trial measured a combined outcome called the “primary composite endpoint.”
Understanding this composite endpoint is important because it is the number often used in marketing.
What Was Included in the Primary Endpoint
The primary endpoint in the REDUCE-IT trial included five different cardiovascular events
- Cardiovascular death
- Non-fatal heart attack
- Non-fatal stroke
- Coronary revascularization (stents or bypass surgery)
- Hospitalization for unstable angina
Because these events are combined into one endpoint, the overall number of events appears larger.
When the results are broken down individually, the differences are smaller.
What the Trial Found
Over about five years of follow-up
22 percent of patients taking statins alone experienced one of the primary endpoint events.
17.2 percent of patients taking statins plus Vascepa experienced one of the events.
This represents an absolute risk reduction of about 4.8 percent
In practical terms, about 21 patients needed to take Vascepa for nearly five years to prevent one event.
Breaking Down the Individual Outcomes
When the individual components of the endpoint are examined, the absolute differences are relatively small.
Heart attacks
Statin only group
About 8.5 percent experienced a heart attack.
Statin plus Vascepa
About 6.1 percent experienced a heart attack.
Absolute reduction: about 2.4 percent.
Stroke
Statin only group
About 4.1 percent experienced a stroke.
Statin plus Vascepa
About 2.6 percent experienced a stroke.
Absolute reduction: about 1.5 percent.
Coronary procedures (stents or bypass surgery)
Statin only group
About 13.3 percent required a coronary intervention.
Statin plus Vascepa
About 9.2 percent required a procedure.
Absolute reduction: about 4.1 percent.
Unstable angina requiring hospitalization
Statin only group
About 3.7 percent.
Statin plus Vascepa
About 2.1 percent.
Absolute reduction: about 1.6 percent.
Total Mortality
Despite the reduction in some cardiovascular events, Vascepa did not significantly reduce overall death rates.
Side Effects of Vascepa
Although often described as purified fish oil, Vascepa is still a pharmaceutical drug and carries potential risks.
Reported side effects include
- Atrial fibrillation (1.4% higher risk)
- Bleeding complications
- Peripheral swelling
- Joint pain
- Digestive symptoms
The Mineral Oil Placebo Controversy
Another HUGE issue that has raised questions from many cardiologists about the REDUCE-IT results is the type of placebo used.
Instead of an inert substance, the placebo used in the trial was a petroleum based mineral oil.
During the study, the placebo group experienced increases in several cardiovascular risk markers, including:
- LDL cholesterol
- Apolipoprotein B
- C reactive protein
LDL cholesterol rose by roughly 10 percent in the placebo group.
C reactive protein increased by about 30 percent!!!!
These changes suggest the placebo group may have become less healthy during the trial.
If the comparison group worsens, the treatment group can appear more beneficial by comparison.
Other omega 3 drug trials that used different placebo substances have not shown the same dramatic benefits.
Why the Natural Heart Doctor Approach Is Different
Even if Vascepa offers modest benefit in certain high risk patients, it represents a pharmaceutical attempt to replicate something nature already provides.
Seafood contains omega 3 fats in their natural biological context.
Wild caught fish and shellfish deliver:
- EPA
- DHA
- Antioxidants such as astaxanthin
- Selenium and iodine
- Marine phospholipids that help integrate omega 3 fats into cell membranes
These nutrients work together to support healthy blood vessels, balanced inflammation, and healthy heart rhythm.
A single isolated pharmaceutical compound cannot replicate this complexity.
Real Food Versus Pharmaceutical Omega 3
For thousands of years, traditional cultures maintained cardiovascular health through diet rather than pharmaceutical drugs.
Populations with high seafood consumption have historically demonstrated lower rates of cardiovascular disease.
Some of the best sources of marine omega 3 fats include
- Wild caught salmon
- Salmon roe
- Sardines
- Anchovies
- Oysters
- Mussels
These foods provide omega 3 fats together with dozens of other nutrients that support cardiovascular health.
So eat seafood and eat it often.
Instead of a pharmaceutical oil in a capsule, consider our Wild Salmon Roe in a capsule.
